Bringing hope and enhancing care through partnership
The brain tumor specialists at Penn Medicine work closely with leading national organizations such as the American Brain Tumor Association, National Brain Tumor Society, and National Cancer Institute. These partnerships help ensure our providers stay up to date on the latest treatments and therapies, while lending their expertise to the ongoing clinical research of brain tumor diagnosis and treatment.
Through collaboration with Children's Hospital of Philadelphia (CHOP), Penn Medicine has created an extensive collection of blood, DNA, tissue, and health information samples donated by volunteers for research. This information is vital for improving clinical research, growing our knowledge of brain tumor genomics, and translating findings to improvements in personalized medicine.
The Penn Medicine Glioblastoma Multiforme (GBM) Translational Center of Excellence is a national center for personalized brain tumor therapy and is advancing the standard of care for GBM patients. The Penn Medicine team is an international leader in researching and treating glioblastoma. Through a collaborative partnership, the Penn Brain Tumor Center can utilize the advanced technologies needed to increase survival rates and maximize brain function recovery following treatment.